Biliary tract carcinomas: from chemotherapy to targeted therapy
Donatella Marino1, Francesco Leone, Giuliana Cavalloni
1Department of Medical Oncology, University of Turin Medical School, Institute for Cancer Research and Treatment (IRCC), Candiolo, Italy. donatella.marino@ircc.it
Critical Reviews in Oncology/Hematology
|July 20, 2012
Summary
Biliary tract carcinomas (BTC) have a poor prognosis, with surgery often not an option. Systemic therapies, including gemcitabine-cisplatin chemotherapy and emerging targeted treatments, offer hope for patients with advanced BTC.
Area of Science:
- Oncology
- Gastroenterology
- Molecular Biology
Background:
- Biliary tract carcinomas (BTC) are aggressive tumors with poor prognoses.
- Surgery offers the only cure, but many patients have unresectable disease at diagnosis.
- Systemic therapy is crucial for recurrent or metastatic BTC.
Purpose of the Study:
- To review the clinical experience with systemic treatments for BTC.
- To discuss the evolving landscape of targeted therapies in BTC treatment.
- To highlight future directions in managing biliary tract carcinomas.
Main Methods:
- Literature review of systemic treatments for BTC.
- Analysis of current chemotherapy standards (gemcitabine-cisplatin).
- Exploration of targeted therapy trials and molecular insights.
Main Results:
- Gemcitabine-cisplatin is the current standard chemotherapy for BTC.
- Targeted therapies show promising results in early investigations.
- Understanding cholangiocarcinogenesis aids in developing new treatments.
Conclusions:
- Systemic therapy is vital for advanced BTC.
- Targeted therapies represent a promising future for BTC management.
- Continued research into molecular mechanisms is essential for improving outcomes.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...